Aim: Elastic fiber deposition is a cause of irreversibility of liver fibrosis. However, to date, its relevance to clinical features has not yet been clarified. This study aimed to clarify the correlation between non-invasive markers of fibrosis and fiber quantity, including elastic fiber, obtained from computational analysis.
INTRODUCTION
H EPATITIS C VIRUS is a major cause of chronic hepatitis worldwide and is the leading cause of cirrhosis and hepatocellular carcinoma (HCC) in Japan. 1, 2 In the past, all oral direct-acting antivirals (DAAs) dramatically changed the treatment strategy of hepatitis C virus (HCV) infection; subsequently, the sustained virological response (SVR) rate increased to almost 100%. However, a problem still exists: even after obtaining SVR, patients can progress to decompensated cirrhosis and/or develop HCC. Advanced fibrosis is one of the confirmed risks that correlate with these events; previously, fibrosis stage could only be evaluated through an invasive method, that is, liver biopsy. To address this challenge, several non-invasive techniques have been developed and are frequently used in clinical settings. For example, values calculated by certain formulae, such as Fibrosis-4 (FIB-4), 3 elastography measured by ultrasound or magnetic resonance imaging, 4 or a serum marker, such as Wisteria floribunda agglutininpositive Mac-2 binding protein (WFA + -M2BP), 5 are considered associated with fibrosis stage. Specifically, WFA + -M2BP is a novel serum biomarker that was originally reported to correlate with liver fibrosis in patients with HCV infection. 5 Recently, this marker was found to be useful for predicting fibrosis severity in chronic liver injury from many etiologies [6] [7] [8] [9] [10] and practical for the risk assessment of HCC development as well. [11] [12] [13] [14] The main pathological feature in liver fibrosis is the accumulation of collagen fiber. However, recent studies using animal models have revealed that elastic as well as collagen fibers play significant roles in advanced fibrosis. Reportedly, elastic fibers accumulate due to insufficient degradation as a result of matrix metalloproteinase-12 downregulation, 15 which subsequently causes the crosslinking of collagen fibers, and this could be one reason for the irreversibility of liver fibrosis. 16 Although the deposition of elastic fibers in advanced fibrosis has been widely recognized in various types of chronic hepatitis, 17, 18 the small quantity of elastin in clinical specimens made its analysis challenging. Nowadays, as pathological assessment of liver biopsy specimens has made great progress, imaging technology has enabled us to undertake super-highresolution computational analysis 19 and quantification of fibers, even in small amounts. Using this technique, we have reported that elastic fiber deposition is an independent factor associated with HCC development in patients with advanced fibrosis-staged hepatitis C patients. 20 However, the correlation of non-invasive assessment with the quantity of fibers, particularly the deposition of elastic fiber, remains unknown. Hence, this study aimed to clarify the usefulness of non-invasive assessment for predicting liver fibrosis, particularly elastic fiber accumulation.
METHODS

Patients
T HIS RETROSPECTIVE COHORT study involved patients with HCV infection who underwent liver biopsy prior to DAA therapy at our hospital between January 2014 and October 2016. Among these patients, 270 were assessed using non-invasive methods to determine the degree of liver fibrosis within 3 months before the biopsy. Of these patients, 95 underwent magnetic resonance elastography (MRE) and 262 had evaluable serum samples including WFA + -M2BP. This retrospective cohort study was approved by the institutional ethical review board of our hospital on 13 March 2017 (no. 28079). Written informed consent was obtained from every patient, and the study protocol conformed to the ethical guidelines of the Declaration of Helsinki 1975.
Liver biopsy and pathological assessment
Liver biopsy was carried out using a 16G core needle biopsy kit with ultrasonography guide or using a 13G Silverman needle laparoscopically. Liver biopsy specimens <10 mm and that contained only a few portal triads were excluded from this study because these specimens could not be evaluated accurately with either conventional fibrosis staging or computational analysis. Liver biopsy specimens were fixed in a paraffin-embedded block, cut to 4-μm-thick slices, and stained with hematoxylin-eosin, Masson's trichrome, and Elastica van Gieson stain. Fibrosis stage was scored by two board-certified pathologists blinded to any clinical data according to the METAVIR scoring system.
Quantification of fibers in liver biopsy specimens
Elastica van Gieson-stained sections were scanned using a NanoZoomer 2.0HT scanner (Hamamatsu Photonics, Hamamatsu, Japan) with a 20× objective lens. Scanned data were automatically analyzed by computational methods detailed in our previous reports. [19] [20] [21] Fiber amounts were quantified pixel by pixel for collagen and elastic fibers. The size of one pixel was 0.46 μm × 0.46 μm. Each fiber's percentage of total specimen was used in the present study (Fig. 1) . The total fiber quantity was calculated by the sum of collagen and elastic fibers.
Non-invasive liver fibrosis assessment
The Fibrosis-4 (FIB-4) index was calculated using the following formula: FIB-4 index = age (years) × aspartate aminotransferase (AST) (U/L) / (platelet count (10 9 / L) × √alanine aminotransferase (U/L). 22 The AST to platelet ratio index (APRI) was calculated with the following formula: APRI = (AST [U/L] / upper limit of normal of AST [U/L]) × 100 / platelet count (10 9 /L). 23 Magnetic resonance elastography was carried out using a 1.5-T clinical scanner (MRI Signa HDxt 1.5 T; GE Healthcare, Waukesha, WI, USA) using the MR Touch system. The active driver located outside the magnetic resonance imaging room generated 60-Hz mechanical waves and stimulated the passive driver placed on the right anterior chest wall of the patient. Patients were fasting for at least 3 h before MRE, and the images were captured in one short breath-hold. Two independent hepatologists (N.T. and M.H.), who were blinded to the clinical or pathological results, measured the automatically generated stiffness map. Each hepatologist evaluated three different slices, and the mean value for each patient was used in this study.
The measurement of serum WFA + -M2BP was carried out using the automatic immune analyzer HISCL-2000i (Sysmex, Kobe, Japan) by a lectin-antibody sandwich immunoassay.
Statistical analysis
s rank correlation test was carried out. All tests were two-sided, and significance was defined with P < 0.05. For the comparison of three different groups, the Kruskal-Wallis test was applied, followed by P-value adjustment by the Bonferroni method. For example, if we compared four different groups, we adjusted the P-value for significance as 0.008 (≈0.05/6). All statistical analyses were undertaken using EZR software (Saitama Medical Center, Jichi Medical University, Saitama, Japan), a graphical interface version of R statistics (The R Foundation for Statistical Computing, Vienna, Austria).
RESULTS
Patient characteristics
F ROM JANUARY 2014 to October 2016, 464 patients with HCV infection underwent liver biopsy. Among these patients, 194 were excluded from the present study because of: (i) absence of relevant data for non-invasive liver fibrosis assessment (n = 168); (ii) insufficient material of liver biopsy specimen (n = 20); and (iii) liver biopsy specimen revealed a tumor (n = 6). Table 1 describes the baseline characteristics of the 270 patients included in this study.
Conventional fibrosis staging and fiber quantification
When METAVIR stage was compared with fiber quantification, the total fiber quantity showed significant linear correlation with fibrosis stage F0-F4 ( Fig. 2a ; P < 0.001). Similar linearity was also observed for collagen fiber (Fig. 2b) . However, elastic fiber quantity significantly increased only from stage F2 to F3 (Fig. 2c) . The median amount of total, collagen, and elastic fibers in each fibrosis stage is shown in Table 2 .
Non-invasive liver fibrosis assessment was also useful for evaluating the correlation with the conventional staging method. The FIB-4 index along with WFA + -M2BP values significantly increased from stage F0-1 to F2 (P < 0.001; Fig. 2d,e) , whereas liver stiffness values by MRE significantly increased from F2 to F3 (P < 0.001; Fig. 2f ).
Fiber quantification comparing non-invasive liver fibrosis assessment
Spearman's rank correlation test was applied to elucidate the clinical significance of non-invasive liver fibrosis assessment (Fig. 3 ). Significant correlations were observed between total fiber quantity and FIB-4 index (r = 0.361, P < 0.001), WFA To clarify the significance of these markers, we investigated another kind of serum fibrosis marker, APRI, which showed similar results compared to those with FIB-4 index (total fiber, r = 0.433; collagen fiber, r = 0.438; elastic fiber, r = 0.341). Optimal cut-off for predicting higher accumulation of elastic fibers
As was described in our previous report, elastic fiber >3.6% is an independent risk factor for HCC development. To determine the optimal cut-off value for predicting patients whose elastic fiber accumulation is >3.6%, we undertook receiver operating characteristic (ROC) curve analyses. The optimal cut-off value for FIB-4 index, WFA + -M2BP, and liver stiffness by MRE was 3.72 (area under the ROC curve [AUROC], 0.731; specificity, 0.773; sensitivity, 0.611), 1.39 cut-off index (AUROC, 0.716; specificity, 0.402; sensitivity, 0.912), and 4.6 kPa (AUROC, 0.822; specificity, 0.806; sensitivity, 0.758), respectively (Fig. 4) . Table 3 shows the positive and negative predictive values of patients with high elastic fiber quantity. Although the number of patients included in each method was different, the positive predictive value was the highest in MRE and the negative predictive value was the highest in WFA + -M2BP.
DISCUSSION
O UR STUDY REVEALED the correlation between clinical features and fiber quantification. First, elastic fibers relatively increased in the advanced fibrosis stage, from F2 to F3. Second, FIB-4 index and WFA + -M2BP were significantly correlated with fiber quantity and found to be particularly useful for distinguishing low-to-intermediate fiber amounts. Third, liver stiffness by MRE was significantly correlated with fiber quantity, including elastic fiber quantity, and found to be particularly useful for distinguishing intermediate-to-high fiber amounts.
The major focus of the present study is assessment from the viewpoint of quantitative pathology. Assessing fiber quantity as a continuous variable enabled us to analyze the definite correlation of values obtained from noninvasive assessment. 19 Although morphological changes observed through fibrosis development are essential for understanding the pathophysiology of liver fibrosis, distinguishing the type of fibers is necessary to subclassify patients with advanced fibrosis because elastic fibers increase from fibrosis stage F3, according to the present study.
Elastic fibers are reportedly produced by portal fibroblasts 24 and are distinct in portal areas. 21 Elastic fibers in the portal region have been suggested to act as mechanical stabilizers of the bile duct or portal tract for adapting to increased pressure. [25] [26] [27] Elastic fibers are known to cross-link collagen fibers in the advanced stage of chronic liver disease. More specifically, the amino acids that cross-link elastic fiber itself, desmosine and isodesmosine, were reported to increase in patients with bridging fibrosis or cirrhosis. 28 Similarly, serum levels of degraded elastin were reportedly only elevated in patients with portal hypertension. 29 In addition, a histopathological study reported that elastic 31 however, our study could not clarify whether WFA + -M2BP is useful for subclassifying cirrhosis because only 22 patients with cirrhosis were included in our study. Conversely, MRE now plays a major role in non-invasive liver fibrosis assessment worldwide, 32, 33 although its limited availability and high cost are frequently discussed. 34 Our data confirmed the significance of MRE in correlation with the accumulated fiber quantity in addition to pathological fibrosis stage. Moreover, liver stiffness by MRE significantly surged from stage F2 to F3, similar to elastic fiber quantity. This result reflected the high AUROC of MRE for predicting high amounts of elastic fiber. Furthermore, another important finding of the present study is that WFA + -M2BP and liver stiffness by MRE significantly correlated with each kind of fiber, collagen and elastin alone.
This study has several limitations. First, it is a singlecenter, retrospective study with a relatively small number of patients. Second, the number of patients in the assessment of non-invasive techniques for liver fibrosis differs; therefore, the predictability of these methods could not be compared with each other statistically. In addition, as our study only investigated the significance of WFA + -M2BP, the usefulness of other serum fibrosis markers, such as hyaluronic acid and type IV collagen, was not determined. Third, the prediction of patients with highly accumulated elastic fiber overlaps with patients with highly accumulated total fiber. Therefore, we could not determine whether the cut-off values obtained from ROC analyses are truly useful for prediction of the elastic fiber quantity specifically. A larger clinical study would be necessary for clarifying this problem along with basic research for understanding elastic fiber synthesis and degradation in chronic liver disease.
In conclusion, fiber quantitative analyses in patients with chronic HCV infection revealed that non-invasive liver fibrosis assessment significantly correlates with not only collagen fiber but also elastic fiber quantity. Moreover, MRE was useful for predicting high amounts of elastic fiber.
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